Warsaw-based Jutro Medical, an AI-first
primary care operator combining online and in-person care, has raised €24
million in new funding led by Warsaw Equity Group, with participation from
Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo
VC. The round also includes a debt component from mBank and Orbit Capital. The
raise extends the company’s previously announced Series A, bringing the total
to €36 million.
Founded in 2020, Jutro Medical has grown from
a single clinic focused on technology-enabled care into an integrated primary
care operator with its own electronic health record (EHR), standardised clinic
operations, and AI-based tools.
In its first four years, Jutro Medical
prioritised building a proprietary EHR and the underlying software and data
infrastructure used across its clinics. The company says this foundation has
enabled it to add an AI layer more efficiently, allowing AI agents to support
administrative tasks such as intake and drafting visit documentation.
Clinicians begin appointments with relevant context prepared, review and adjust
information as needed, and retain responsibility for all clinical decisions.
Use of AI is optional, and patients can choose a traditional appointment.
The company’s approach is positioned against
broader pressures in primary care, where workforce shortages, rising
administrative workloads, and uneven access continue to limit capacity. Primary
care spending in Europe exceeds €200 billion annually, including around €9
billion in Poland, yet many clinics still rely on manual or paper-based
processes that can slow access to care.
Jutro Medical follows an acquisition-led
strategy, bringing acquired clinics onto a shared operating and technology
platform that includes a common EHR, workflows, and AI tools. The company says
it added nine clinics to its network this year and is targeting around 20
acquisitions annually, with the aim of supporting more consistent service
delivery and faster integration.
By running our own clinics on our own
software, we’ve learned firsthand which tasks can be handled by AI. Instead of
hiring more staff, we now build AI agents that do the same work – freeing
clinicians to practice medicine, not paperwork. These agents already manage
thousands of patients interactions every month,
says Adam Janczewski, founder and CEO of Jutro
Medical.
The new capital will be used to support further
clinic acquisitions in Poland and to expand the model into other European
markets. Jutro Medical also plans to continue developing AI agents to automate
additional administrative and operational tasks, while clinicians focus on
diagnosis and treatment.
Over the longer term, the company aims to build a
pan-European primary care operator by consolidating a fragmented market of
small practices.